RSS
|
Login
|
Register
Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Editorial Calendar
Issue Archive
Events
MM&M Awards
Webcasts
Podcasts
Surveys
Directories
PMD
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Jobs
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
Media Notepad Articles
Boston Ventures acquires Oakstone Publishing
July 14, 2008
Oakstone Publishing has been acquired by private equity firm Boston Ventures.
AARC names publisher, head of scientific publishing division
July 14, 2008
The American Association for Cancer Research (AARC) has appointed Diane Scott-Lichter as publisher and head of its scientific publishing division.
Wolters Kluwer expands content
Ben Comer
July 14, 2008
Lippincott's Nursing Procedures and Skills has been upgraded to provide hospitals with over 200 pediatric procedures.
Oncology portal registers over 12,000
Ben Comer
July 14, 2008
Elsevier's OncologySTAT portal has attracted over 12,000 registrants since its September 2007 launch.
STM journals seek interaction online
Ben Comer
July 01, 2008
Integrating online strategy into an ever-changing digital environment is no easy task for pharma marketers.
Merck a leader in video detailing
Ben Comer
July 01, 2008
In 2007, ePromotion increased by 20% in terms of media spend, with Merck leading the charge, said Tara Hann, director of client services at Verispan.
QHI names new group publisher
June 01, 2008
Quadrant Healthcom Inc. (QHI) has named Eileen Hubert group publisher for Neurology Reviews and NeuroPsychiatry Reviews.
AHA launches extension of its flagship journal
June 01, 2008
The American Heart Association has launched Circulation: Arrhythmia and Electrophysiology, an extension of its flagship journal.
PeerView completes acquisition of VCTR
June 01, 2008
PeerView has completed the acquisition of the Veritas Clinical Trials Register platform from Veritas Medicine.
JAMA lambastes Vioxx articles
Ben Comer
June 01, 2008
The Journal of the American Medical Association called into question published clinical data and authorship surrounding Merck's Vioxx (rofecoxib) in a scathing editorial.
« Previous
Next »
Most Popular
Most Emailed
Most Recent
Everyday Health climbs past WebMD
Most Zyrtec users didn't switch to OTC
J&J consolidation splits Rx brands between two holding companies
Baucus health plan would mandate gifts disclosure
WebMD, QualtyHealth.com merger terminated
DoJ recovered $694.5 million from drug and device manufacturers in 2008
MedPac to Congress: Make pharmas report all samples to HHS
Motrin viral suffers digital slings and arrows
Court rules against IMS, SDI on NH data ban
Congress to investigate FDA's medical device approval process
Online detailing taking off: study
Sales Force Report: Loop of Faith
J&J consolidation splits Rx brands between two holding companies
J&J buys wellness firm HealthMedia
Everyday Health climbs past WebMD
The anatomy of an email
Merck slashes 7,200 jobs, pursues more customer-centric selling model
SK&A launches doc verification tool
Glaxo's sales force downsized by 12%
Most Zyrtec users didn't switch to OTC
AstraZeneca cuts jobs, closes factories
DTC spend lags as firms scrimp on launches, says TNS
Customer service portals spark physician interest, not participation
WebMD, QualtyHealth.com merger terminated
Court rules against IMS, SDI on NH data ban
J&J consolidation splits Rx brands between two holding companies
Motrin viral suffers digital slings and arrows
Congress to investigate FDA's medical device approval process
Baucus health plan would mandate gifts disclosure
FDA public relations contract scrutinized by Congress
Popular Tags
Advertising
Agency
Biotech
Business
Consumer
Continuing medical education (CME)
Creative
Digital
Direct marketing
Direct to consumer (DTC)
Downsize
FDA
Government
Launch
Legal
Magazine
Marketing & Communications
Marketing Research
Media
Online
Over the counter (OTC)
Pharmaceutical
Regulatory
Sales force
Trend